/2017 (for the equity holders of the Company) was THB 36.65 million, an increase of THB 8.85 million or of 31.83% from the same period last year (Q3/2017 : THB 27.80 million). The Growth in revenues and

-47.86 million, Baht - 50.16 million and Baht -29.12 million in Q1, Q2 and Q3 2017 respectively. Considering the sustainable growth, the company is in the process of launching the new business concept with

the main trading currency of the company), resulting in the company recognized revenue from sales of foreign currency decreased For domestic market, revenue from sales increase lightly due to growth of

shares of Pek Industries Co., Ltd. at Baht 800.80 per share, totally Baht 5,600,000 for managing excess liquidity and gaining opportunity to invest in new business expecting good business growth. 10

Baht or 22.68% due to overall growth of the market. The company recorded domestic sales of 687.94 million Baht which increased from the same quarter last year totaling 162.91 million Baht or 31.03

opportunity to invest in new business expecting good business growth. 10) Opinions by Audit Committee - None - 11) Transaction Type : The Transaction as stated above would be within scope of the related

, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the

will meet the demand of the customers, which will increase Company’s competitiveness and continuously maintain growth rate of the Company. (9) Source of Funds : The Subsidiary will use its term loans and

period of last year by Baht 44.2 million or 12.9%. The major reason for the incremental is from same store sale growth at 10.5% and new branches opened during the year 2018 at 6.8%. Which during the period

result of new branch opening at The Mall Bangkapi in October 2018, resulting in the growth in this quarter revenue recognition compared to last year. Moreover, the group has opened a new branch at Central